Procurent of Xofluza (baloxavir Marboxil) 40MG and 80MG Tablets
Contract Overview
Contract Amount: $37,485,000 ($37.5M)
Contractor: Genentech USA, Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2025-09-26
End Date: 2027-09-29
Contract Duration: 733 days
Daily Burn Rate: $51.1K/day
Official Description: PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS
Place of Performance
Location: California, 94080